Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Intellikine logo — Pioneering novel therapies by creating exceptional teams and...

Intellikine

Pioneering novel therapies by creating exceptional teams and powerful platforms for rapid discovery in the PI3K/Akt/mTOR pathway.

Founded 2007 Series Unknown Total: $85.00M Biotechnology, Health Care

General Information

Company Name Intellikine
Founded Year 2007
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Intellikine moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Intellikine

Intellikine is a biotechnology company founded in 2007, specializing in the development of innovative small molecule therapies targeting the PI3K/Akt/mTOR pathway. With a focus on creating exceptional teams and powerful platforms for rapid discovery, Intellikine is dedicated to swiftly producing small molecule kinase inhibitor drug candidates that are poised to revolutionize the medical industry. The company recently received a $4.00M Venture Round investment in October 31, 2011. Operating within the Biotechnology and Health Care sectors, Intellikine stands at the forefront of pioneering novel therapies.

Taxonomy: pharmaceuticals, drug discovery, medical innovation, small molecule therapies, PI3K/Akt/mTOR pathway, kinase inhibitors, team building, discovery platform, startup, investment potential

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 31 Oct 2011
Series B •••••• 6
Investor Investor Investor Investor Investor
•••• •••• 		22 Jul 2009
Series B •••••• 1
Investor
01 Jun 2007

Intellikine Alternatives & Competitors

Intellikine vs
Fochon Pharmaceuticals
Fochon Pharmaceuticals

Pioneering small molecule therapies for cancer and metabolic illnesses, advancing from discovery to...

11-50 employees
Biotechnology, Health Care
Intellikine vs
Applied Discoveries Inc.
Applied Discoveries Inc. United States

Unlocking the Potential of Natural Compounds.

1 employees
Biopharma, Biotechnology
Intellikine vs
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. United States

Precision Science Inspired by Human Biology

Acquired
271 employees
Biotechnology, Health Care

FAQ About Intellikine

Pioneering novel therapies by creating exceptional teams and powerful platforms for rapid discovery in the PI3K/Akt/mTOR pathway.
Intellikine was founded in 2007.
Intellikine operates in the following industries: Biotechnology, Health Care.
Intellikine has completed 3 funding rounds, raising a total of $85.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Intellikine include Fochon Pharmaceuticals, Applied Discoveries Inc., Vividion Therapeutics, Inc., Calyxha Biotechnologies, Terray Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Intellikine and Fochon Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Intellikine and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes